Advertisement

Pharmacy

Moderna will not enforce the patents it gained for its experimental COVID-19 vaccine and will license its COVID-19 vaccine intellectual property to other drugmakers after the pandemic is declared over, the drugmaker announced Oct. 8.

President Donald Trump and White House Chief of Staff Mark Meadows are both urging the FDA to quickly grant an emergency use authorization for Regeneron's antibody drug, which the president received as a treatment for COVID-19, The Washington Post reported. 

Advertisement
Advertisement